Ocrevus Archives -

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

https://pharmaphorum.com/news/nice-says-yes-to-novartis-multiple-sclerosis-therapy-kesimpta/

Roche hits back at Novartis with new data for MS drug Ocrevus

https://pharmaphorum.com/news/roche-hits-back-at-novartis-with-new-data-for-ms-drug-ocrevus/

US, EU reviews start for Novartis’ Ocrevus rival ofatumumab

https://pharmaphorum.com/news/us-eu-reviews-start-for-novartis-ocrevus-rival-ofatumumab/

Roche raises 2019 outlook, shrugging off biosimilar threat

https://pharmaphorum.com/news/roche-raises-2019-outlook-shrugging-off-biosimilar-threat/

Addressing MS’ two-tier healthcare system is about ‘social justice’

https://pharmaphorum.com/views-analysis-patients/ms-two-tier-healthcare-system/

Roche’s MS drug Ocrevus earns blockbuster status a year after launch

https://pharmaphorum.com/news/roche-ms-ocrevus-blockbuster/

Roche’s MS drug Ocrevus nears European market

https://pharmaphorum.com/news/roches-multiple-sclerosis-drug-ocrevus-heading-european-market-received-backing-regulators/

Brain infection would be bad news for Roche’s MS drug Ocrevus

https://pharmaphorum.com/news/roche-investigates-ocrevus/

Search